Earnings call transcript: Repligen Q3 2025 earnings beat expectations, stock rises
PositiveFinancial Markets

Repligen's Q3 2025 earnings report has exceeded expectations, leading to a rise in its stock price. This positive performance highlights the company's strong market position and effective strategies, which could attract more investors and boost confidence in the biotech sector.
— Curated by the World Pulse Now AI Editorial System









